Zekocid 40 Tablet contains Pantoprazole 40mg, a proton pump inhibitor used to reduce gastric acid secretion. It is primarily indicated for the treatment of gastroesophageal reflux disease (GERD), erosive esophagitis, Zollinger-Ellison syndrome, and other conditions involving excessive stomach acid production. Pantoprazole acts by irreversibly inhibiting the H+/K+ ATPase enzyme system at the secretory surface of gastric parietal cells, thereby suppressing the final step in acid production. This leads to a significant and prolonged reduction in gastric acidity, promoting healing of acid-related damage and relief of symptoms such as heartburn and acid regurgitation. Zekocid 40 is typically administered orally, once daily, preferably before meals. The tablet is well tolerated, with common side effects including headache, diarrhea, nausea, and abdominal pain. It is contraindicated in patients with known hypersensitivity to pantoprazole or other proton pump inhibitors. Caution is advised in patients with severe liver impairment. Long-term use should be monitored due to potential risks such as vitamin B12 deficiency and increased susceptibility to gastrointestinal infections. Zekocid 40 offers effective acid suppression, improving patient quality of life in acid-related gastrointestinal disorders.